189 related articles for article (PubMed ID: 25098730)
1. The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.
Lee CG; Lim YJ; Park SJ; Jang BI; Choi SR; Kim JK; Kim YT; Cho JY; Yang CH; Chun HJ; Song SY;
BMC Cancer; 2014 Aug; 14():569. PubMed ID: 25098730
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine Tumors of the Esophagus: State of the Art in Diagnostic and Therapeutic Management.
Schizas D; Mastoraki A; Kirkilesis GI; Sioulas AD; Papanikolaou IS; Misiakos EP; Arkadopoulos N; Liakakos T
J Gastrointest Cancer; 2017 Dec; 48(4):299-304. PubMed ID: 28656561
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
5. Predicting Survival and Response to Treatment in Gastroesophageal Neuroendocrine Tumors: An Analysis of the National Cancer Database.
Gray KD; Moore MD; Panjwani S; Elmously A; Afaneh C; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2018 May; 25(5):1418-1424. PubMed ID: 29476295
[TBL] [Abstract][Full Text] [Related]
6. Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumors.
Jiao X; Wang Z; Peng X; Zhang L; Zhou L
Future Oncol; 2020 Oct; 16(28):2197-2207. PubMed ID: 32687408
[No Abstract] [Full Text] [Related]
7. Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study.
Paik WH; Lee HS; Lee KJ; Jang SI; Lee WJ; Hwang JH; Cho CM; Park CH; Han J; Woo SM; Jeong S; Chon HK; Kim TN; Lee JK; Han JH; Yoon JH; Kim YT; Cho JH
Pancreatology; 2021 Jan; 21(1):208-214. PubMed ID: 33281058
[TBL] [Abstract][Full Text] [Related]
8. Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumors.
Yazici C; Boulay BR
World J Gastroenterol; 2017 Jul; 23(27):4847-4855. PubMed ID: 28785139
[TBL] [Abstract][Full Text] [Related]
9. Rectal NETs and rectosigmoid junction NETs may need to be treated differently.
Cai W; Ge W; Hu H; Mao J
Cancer Med; 2020 Feb; 9(3):971-979. PubMed ID: 31840409
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and outcome of esophageal neuroendocrine tumor: A retrospective multicenter survey by the digestive endoscopy society of Taiwan.
Wu IC; Chu YY; Wang YK; Tsai CL; Lin JC; Kuo CH; Shih HY; Chung CS; Hu ML; Sun WC; Wang JP; Wang HP
J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):508-514. PubMed ID: 32600867
[TBL] [Abstract][Full Text] [Related]
11. Primary neuroendocrine neoplasm of the esophagus - Report of 14 cases from a single institute and review of the literature.
Tustumi F; Takeda FR; Uema RH; Pereira GL; Sallum RA; Cecconello I
Arq Gastroenterol; 2017; 54(1):4-10. PubMed ID: 28079231
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus.
Miyata H; Sugimura K; Motoori M; Omori T; Yamamoto K; Yanagimoto Y; Shinno N; Yasui M; Takahashi H; Wada H; Ohue M; Yano M
Surgery; 2019 Dec; 166(6):1033-1040. PubMed ID: 31493901
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.
Nishikawa Y; Chino A; Ide D; Saito S; Igarashi M; Takamatsu M; Fujisaki J; Igarashi Y
Int J Colorectal Dis; 2019 Nov; 34(11):1887-1894. PubMed ID: 31630212
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single-center study.
Song L; Zhai X; Yu S; Ma Y; Wang F; Yu X; Tao S; Lian Y; Yang M; Tao W; Fan Q
Cancer Med; 2019 Jul; 8(8):3729-3737. PubMed ID: 31127690
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine Tumors.
Blakely AM; Lafaro KJ; Li D; Kessler J; Chang S; Ituarte PHG; Lee B; Singh G
Neuroendocrinology; 2020; 110(5):384-392. PubMed ID: 31401633
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
Yoshii T; Ohkawa S; Tamai S; Kameda Y
Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
[TBL] [Abstract][Full Text] [Related]
18. A rare rarity: Neuroendocrine tumor of the esophagus.
Giannetta E; Guarnotta V; Rota F; de Cicco F; Grillo F; Colao A; Faggiano A;
Crit Rev Oncol Hematol; 2019 May; 137():92-107. PubMed ID: 31014519
[TBL] [Abstract][Full Text] [Related]
19. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.
Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S
Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765
[TBL] [Abstract][Full Text] [Related]
20. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
